ORG Wealth Partners LLC Acquires New Shares in Astera Labs, Inc. (NASDAQ:ALAB)

ORG Wealth Partners LLC acquired a new stake in Astera Labs, Inc. (NASDAQ:ALABFree Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 319 shares of the company’s stock, valued at approximately $42,000.

Several other hedge funds have also recently bought and sold shares of the company. Everence Capital Management Inc. purchased a new position in Astera Labs during the fourth quarter worth $513,000. GAMMA Investing LLC increased its position in Astera Labs by 78.3% during the fourth quarter. GAMMA Investing LLC now owns 510 shares of the company’s stock worth $68,000 after buying an additional 224 shares in the last quarter. JPMorgan Chase & Co. increased its position in Astera Labs by 3.1% during the third quarter. JPMorgan Chase & Co. now owns 1,568,314 shares of the company’s stock worth $82,164,000 after buying an additional 47,569 shares in the last quarter. Tidal Investments LLC increased its position in Astera Labs by 81.8% during the third quarter. Tidal Investments LLC now owns 45,298 shares of the company’s stock worth $2,373,000 after buying an additional 20,388 shares in the last quarter. Finally, Sanctuary Advisors LLC purchased a new position in Astera Labs during the third quarter worth $203,000. 60.47% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other Astera Labs news, Director Manuel Alba sold 11,000 shares of the business’s stock in a transaction dated Wednesday, December 4th. The stock was sold at an average price of $117.50, for a total transaction of $1,292,500.00. Following the transaction, the director now owns 456,863 shares in the company, valued at $53,681,402.50. The trade was a 2.35 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Jitendra Mohan sold 171,064 shares of the business’s stock in a transaction dated Thursday, November 21st. The stock was sold at an average price of $103.53, for a total value of $17,710,255.92. Following the transaction, the chief executive officer now owns 628,895 shares in the company, valued at approximately $65,109,499.35. This represents a 21.38 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 1,690,452 shares of company stock worth $167,581,256 over the last quarter.

Wall Street Analyst Weigh In

Several equities analysts have weighed in on the company. Morgan Stanley raised their price target on Astera Labs from $94.00 to $142.00 and gave the stock an “overweight” rating in a research report on Friday, December 20th. Northland Securities downgraded Astera Labs from an “outperform” rating to a “market perform” rating and raised their price target for the stock from $100.00 to $120.00 in a research report on Thursday, January 2nd. Roth Mkm raised their price objective on Astera Labs from $80.00 to $105.00 and gave the stock a “buy” rating in a report on Tuesday, November 5th. Stifel Nicolaus raised their price objective on Astera Labs from $100.00 to $150.00 and gave the stock a “buy” rating in a report on Monday, January 6th. Finally, Citigroup began coverage on Astera Labs in a report on Monday, November 18th. They set a “buy” rating and a $120.00 price objective on the stock. Two research analysts have rated the stock with a hold rating and eleven have given a buy rating to the company’s stock. According to MarketBeat, Astera Labs has a consensus rating of “Moderate Buy” and a consensus price target of $105.75.

Get Our Latest Research Report on Astera Labs

Astera Labs Trading Down 0.8 %

Shares of Astera Labs stock opened at $129.70 on Friday. Astera Labs, Inc. has a twelve month low of $36.22 and a twelve month high of $147.39. The business’s fifty day moving average price is $115.73 and its 200 day moving average price is $74.04.

Astera Labs (NASDAQ:ALABGet Free Report) last issued its earnings results on Monday, November 4th. The company reported $0.23 earnings per share for the quarter, beating analysts’ consensus estimates of $0.17 by $0.06. Astera Labs had a negative return on equity of 15.57% and a negative net margin of 30.69%. The firm had revenue of $113.10 million for the quarter, compared to analysts’ expectations of $97.50 million. The business’s revenue was up 47.1% compared to the same quarter last year. On average, research analysts predict that Astera Labs, Inc. will post -0.45 earnings per share for the current fiscal year.

About Astera Labs

(Free Report)

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.

Read More

Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALABFree Report).

Institutional Ownership by Quarter for Astera Labs (NASDAQ:ALAB)

Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.